You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/35535
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPlaneta, Cleopatra da Silva-
dc.contributor.authorDelucia, R.-
dc.contributor.authorAizenstein, M. L.-
dc.date.accessioned2014-05-20T15:25:03Z-
dc.date.accessioned2016-10-25T17:59:25Z-
dc.date.available2014-05-20T15:25:03Z-
dc.date.available2016-10-25T17:59:25Z-
dc.date.issued1995-06-01-
dc.identifierhttp://www.scielo.br/scielo.php?script=sci_issues&pid=0100-879X&lng=en&nrm=iso-
dc.identifier.citationBrazilian Journal of Medical and Biological Research. São Paulo: Associação Bras Divulg Cientifica, v. 28, n. 6, p. 667-670, 1995.-
dc.identifier.issn0100-879X-
dc.identifier.urihttp://hdl.handle.net/11449/35535-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/35535-
dc.description.abstractFencamfamine (FCF) is a CNS stimulant that facilitates central dopaminergic transmission primarily through blockade of dopamine uptake. In the present study we evaluated the relationship between plasma FCF concentration and behavioral sensitization effect. Adult male Wistar rats (250-300 g) received FCF (10 mg/kg, kg, ip) or saline once or daily for 10 consecutive days (N = 10 for each group). Blood samples were collected 30 min after injections and plasma FCF was measured by gas chromatography using an electron capture detector. FCF treatment enhanced sniffing duration (16.8 +/- 0.8 vs 26.6 +/- 0.9 s) and decreased rearing behavior (8.2 +/- 0.8 vs 3.7 +/- 0.6 s) when days 1 and 10 of drug administration were compared. Comparison of pair of means by the Student t-test did not show significant differences in plasma FCF concentration (390 +/- 40 vs 420 +/- 11 ng/ml) when blood samples were collected 30 min after acute FCF administration or after daily administration of 10 mg/kg for 10 days. In conclusion, the behavioral sensitization to FCF could not be correlated with plasma drug levels, and changes in the activity of dopaminergic systems should be considered to explain the sensitization to the effect of FCF.en
dc.format.extent667-670-
dc.language.isoeng-
dc.publisherAssociação Brasileira de Divulgação Científica (ABRADIC)-
dc.sourceWeb of Science-
dc.subjectFENCAMFAMINEpt
dc.subjectPLASMA FENCAMFAMINE LEVELSpt
dc.subjectBEHAVIORAL SENSITIZATIONpt
dc.subjectDOPAMINERGIC SYSTEMSpt
dc.titleTHE BEHAVIORAL SENSITIZATION INDUCED BY FENCAMFAMINE IS NOT RELATED TO PLASMA DRUG LEVELSen
dc.typeoutro-
dc.contributor.institutionUniversidade de São Paulo (USP)-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationUNIV SAO PAULO, INST CIENCIAS BIOMED, DEPT FARMACOL, BR-05389970 SAO PAULO, BRAZIL-
dc.description.affiliationUNIV ESTADUAL PAULISTA, FAC CIENCIAS FARMACEUT, DEPT PRINCIPIOS ATIVOS NAT & TOXICOL, BR-14801902 ARARAQUARA, SP, BRAZIL-
dc.description.affiliationUnespUNIV ESTADUAL PAULISTA, FAC CIENCIAS FARMACEUT, DEPT PRINCIPIOS ATIVOS NAT & TOXICOL, BR-14801902 ARARAQUARA, SP, BRAZIL-
dc.identifier.wosWOS:A1995RL53700010-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofBrazilian Journal of Medical and Biological Research-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.